Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer
Links shared publicly online about this topic.
- 1,354total visits
Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer
View full resource at medicalnewstoday.com
Tags: Cancer, Chemotherapy, Colorectal Cancer Medication, Ovarian Cancer, Women's Health, Avastin, Roche Pharmaceuticals, Genentech
Most Recently Shared on February 26, 2010 at 11:29 am By:
Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer http://mnt.to/3y8M #ovariancancer
Also Shared By:
Genentech reports results from Phase III study of Avastin in women with advanced ovarian cancer
news-medical.net — “Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study of Avastin (bevacizumab) that showed women with previously untreated advanced ovarian cancer who received Avastin in combination with chemotherapy, followed by the continuation of Avastin alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 12:55 pm By:
Ovarian Cancer News: Genentech reports results from Phase III study of Avastin in women with advanced ovarian ca... http://buzzup.com/zltn
Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer
medicalnewstoday.com — “Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a phase III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women” View full resource at medicalnewstoday.com
Most Recently Shared on February 27, 2010 at 4:04 pm By:
MNT Ovarian Cancer Health News
Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer http://mnt.to/3yfN #ovariancancer
Advertisement
medical_tweets
@medical_tweets
Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer Genentech, Inc... http://bit.ly/9W9nfb
1 year ago...